What it is
A dual GIP/GLP-1 receptor agonist — a class of medications that supports appetite regulation, blood-sugar handling, and weight management by working with the body’s own incretin signaling. At Meridian it is provided as a prescription compounded formulation, prescribed only when a licensed physician determines it is appropriate for you.
Why a provider may consider it
A provider may evaluate tirzepatide when weight management, appetite regulation, metabolic health, or body-composition goals are central to an individual’s assessment — and when history, medications, and laboratory information support safe, supervised use.
- ✓Weight management
- ✓Appetite regulation
- ✓Metabolic health
- ✓Body composition
How it is administered
A once-weekly subcutaneous injection, self-administered at home with training and guidance. Strength is individualized and typically adjusted gradually by the prescribing physician based on response and tolerance — no universal dose is published here.
What Meridian may track
- •Weight trends through weekly check-ins
- •Appetite, energy, and how the plan feels day to day
- •Side effects — especially digestive — so titration can be adjusted early
- •Laboratory information when your physician considers it useful
Important considerations
- —This compounded formulation is not an FDA-approved drug; it is prepared by a licensed pharmacy under a physician’s prescription.
- —Digestive effects — nausea, constipation, or indigestion — are common, especially early, and usually settle as your physician adjusts the plan.
- —Not appropriate for everyone: personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, and pregnancy are among the factors your physician reviews carefully.
- —Lifestyle remains the foundation — your provider may recommend lifestyle optimization alone or another approach entirely.
- —A licensed physician independently decides whether tirzepatide is appropriate for you after reviewing your health information.